Characteristics and prognosis of post-transplant lymphoproliferative disorders within renal allograft: Report from the PTLD.int. Survey

Annals of Transplantation

Volumn 15, Issue 3, 2010, Pages 80-86

  Khedmat, Hossein ^a   Taheri, Saeed ^b  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE

Author keywords

Post transplant lymphoproliferative disorders; Renal allograft; Renal transplantation

Indexed keywords

ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; FEMALE; HUMAN; KIDNEY; KIDNEY TRANSPLANTATION; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL; TRANSPLANTATION;

ADULT; FEMALE; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; LYMPHOMA; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TRANSPLANTS;

EID: 79953179071     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Khedmat H, Taheri S: Early onset post transplantation lymphoproliferative disorders: analysis of international data from 5 studies. Ann Transplant, 2009; 14(3): 74-77
2. Khedmat H, Taheri S: Late onset post transplantation lymphoproliferative disorders: analysis of international data from 5 studies. Ann Transplant, 2009; 14(4): 80-85
3. Khedmat H, Alavian SM, Taheri S: Significance of Epstein-Barr Virus Infection on the Outcome of Renal Transplant Patients with Lymphoproliferative Disorders. Ann Transplant; 2010; 15(2): 40-44
4. Pourfarziani V, Taheri S, Lessan-Pezeshki M et al: Lymphoma after living donor kidney transplantation: an Iranian multicenter experience. Int Urol Nephrol, 2008; 40(4): 1089-94
5. Opelz G, Henderson R: Incidence of non-Hodgkins lymphomas in kidney and heart transplant recipients. Lancet, 1993; 342: 1514-16
6. Boubenider S, Hiesse C, Goupy C et al: Incidence and consequences of posttransplantation lymphoproliferative disorders. J Nephrol, 1997; 10: 136-45
7. Nalesnik MA, Jaffe R, Starlz TE et al: The pathology of posttransplant lymphoproliferative disorder occurring in the setting of cyclosporine A-prednisolone immunosuppression. Am J Pathol, 1988: 133: 173
8. Ali MG, Coakley FV, Hricak H et al: Complex post transplantation abnormalities of renal allografts: evaluation with MR imaging. Radiology, 1999; 211(1): 95-100
9. Lopez-Ben R, Smith JK, Kew CE II et al: Focal post-transplantation lymphoproliferative disorder at the renal allograft hilum. Am J Roentgenol, 2000; 175(5): 1417-22
10. Miller WT Jr, Siegel SG, Montone KT: Posttrans-plantation lymphoproliferative disorder: changing manifestations of disease in a renal transplant population. Crit Rev Diagn Imaging, 1997; 36: 569-85
11. Olcott EW, Goldstein RB, Salvatierra O: Lymphoma presenting as allograft hematoma in a renal transplant recipient. J Ultrasound Med, 1990; 9: 239-41
12. Kirk AD, Cherikh WS, Ring M et al: Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab. Am J Transplant, 2007; 7: 2619-25
13. Zaltzman JS, Prasad R, Chun K et al: Resolution of renal allograft-associated post-transplant lymphoproliferative disorder with the introduction of sirolimus. Nephrol Dial Transplant, 2005; 20(8): 1748-51
14. Carpentier L, Tapiero B, Alvarez F et al: Epstein-Barr virus (EBV) early-antigen serologic testing in conjunction with peripheral blood EBV DNA load as a marker for risk of posttransplantation lympho-proliferative disease. J Infect Dis, 2003; 188: 1853
15. Mamzer-Bruneel MF, Lome C, Morelon E et al: Durable remission after aggressive chemotherapy for very late post-kidney transplant ymphoproliferation: a report of 16 cases observed in a single center. J Clin Oncol, 2000; 18: 3622
16. Karras A, Thervet E, Le Meur Y et al: Successful renal retransplantation after posttransplant lymphoproliferative disease. Am J Transplant, 2004; 4: 1904-9
17. Hickey DP, Nalesnik MA, Vivas CA et al: Renal retransplantation in patients who lost their allografts during management of previous post-trans-plant lymphoproliferative disease. Clin Transplantation, 1990; 4: 187-90
18. Demircin G, Rees L: Retransplantation after posttransplant lymphoproliferative disease. Pediatr Nephrol, 1997; 11: 358-60
19. Birkeland SA, Hamilton-Dutoit S, Bendtzen K: Long-term follow up of kidney transplant patients with posttransplant lymphoproliferative disorder: Duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation. Transplantation, 2003; 76: 153-58
20. Koike J, Yamaguchi Y, Hoshikawa M et al: Post-transplant lymphoproliferative disorders in kidney transplantation: histological and molecular genetic assessment. Clin Transplant, 2002; 16(Suppl.8): 12-17
21. Cockfield SM, Preiksaitis JK, Jewell LD et al: Posttransplant lymphoproliferative disorder in renal allograft recipients. Transplantation, 1993; 56: 88-96
22. Schaar CG, van der Pijl JW, van Hoek B et al: Successful outcome with a quintuple approach of posttransplant lympho-proliferative disorders. Transplantation, 2001: 71: 47
23. Muti G, Cantoni S, Oreste P et al: Post-transplant lympoproliferative disorders: improved outcome after clinico-pathologically tailored treatment. Haematologica, 2002; 87: 67-77
24. Wilde GE, Moore DJ, Bellah RD: Posttransplantation lymphoproliferative disorder in pediatric recipients of solid organ transplants: timing and location of disease. AJR Am J Roentgenol, 2005; 185(5): 1335-41
25. Wasson S, Zafar MN, Best J et al: Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: A single-center experience. J Cardiovasc Pharmacol Therapeut, 2006; 11: 77
26. Bakker NA, Van Imhoff GW, Verschuuren EA et al: Early onset post-transplant lymphoproliferative disease is associated with allograft localization. Clin Transplant, 2005; 19: 327-34
27. Randhawa PS, Magnon M, Joradan M et al: Renal allograft involvement by EBV associated posttransplant lymphoproliferative disease. Am J Surg Path, 1996; 20: 563-71
28. Penn I: Cancers in renal transplant recipients. Adv Ren Replace Ther, 2000; 7: 147
29. Howard TK, Klintmalm GB, Stone MJ et al: Lymphoproliferative disorder masquerading as rejection in liver transplant recipients an early aggressive tumor with atypical presentation. Transplantation, 1992; 53: 1145
30. Trpkov K, Marcussen N, Rayner D et al: Kidney allograft with a lymphocytic infiltrate: acute rejection, posttransplantation lymphoproliferative disorder, neither, or both entities? Am J Kidney Dis, 1997; 30: 449
31. Trofe J, Buell JF, Beebe TM et al: Analysis of factors that influence survival in post-transplant lymphoproliferative disorder in renal transplant recipients: The Israel Penn Transplant Tumor Registry experience. Am J Transplant, 2005; 5: 775-80
32. Cosio FG, Nuovo M, Delgado L et al: EBV kidney allograft infection: possible relationship with a peri-graft localization of PTLD. Am J Transplant, 2004; 4(1): 116-23
33. Hanto DW, Frizzera C, Purtilo DT et al: Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res, 1981; 41: 4253
34. Cohen JI: EBV lymphoproliferative disease associated with acquired immunodeficiency. Medicine, 1991; 70: 137
35. Morrison VA, Dunn DL, Manivel JC et al: Clinical characteristics of post-transplant lymphoproliferative disorders. Am J Med, 1994; 97: 14
36. Knowles DM, Cesarman E, Chadburn A et al: Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of post-transplant lymphoproliferative disorders. Blood, 1995; 85: 552
37. Patton DF, Wikowski CW, Honson CA et al: Epstein-Barr virusdetermined clonality in posttransplant lymphoproliferative disease. Transplantation, 1990; 49: 1080-84
38. Chadburn A, Chen JM, Hsu DT et al: The morphologic and molecular genetic categories of post-transplantation lymphoproliferative disorders are clinically relevant. Cancer, 1998; 82: 1978-87